Gender Affirming Care: Fraud or Mental Disorder?

Gender affirming care remains highly controversial. It involves hormones, puberty blockers, and surgeries to align a person's body with their identified gender. The core question: Is this legitimate medical treatment, or is it either fraud on taxpayers or affirmation of a mental disorder that should be treated differently?

Gender Dysphoria as a Mental Disorder

The DSM-5-TR classifies gender dysphoria as a mental disorder. It involves significant distress from a mismatch between one's experienced gender and assigned sex at birth. If this is a psychiatric condition, affirming it through body modification raises serious concerns.

Treating the distress by altering the body ignores potential underlying issues like trauma, autism, depression, or anxiety. Critics compare it to affirming anorexia by encouraging weight loss. Recent developments show major medical groups shifting stance. In February 2026, the American Society of Plastic Surgeons (ASPS) recommended delaying all gender-related surgeries until at least age 19, citing low-certainty evidence, emerging harms, and regret risks.

The American Medical Association (AMA) agreed that evidence for surgeries on minors is insufficient and supported deferring them to adulthood. Over 40 hospitals have paused or stopped youth gender care amid these changes and legal pressures.

A landmark 2026 malpractice case in New York awarded $2 million to a woman who received a teen double mastectomy and later regretted it, citing inadequate assessment of her mental health issues. This highlights real risks of rushing into irreversible procedures.

If gender dysphoria is a mental disorder, the compassionate approach is therapy to address root causes, not affirmation that may cause permanent harm.

If Not a Disorder, Then Why Taxpayer Funding?

Suppose gender incongruence is not a mental disorder, as some claim via ICD-11 reclassification. Then these interventions become elective or cosmetic, similar to other body-altering procedures not deemed medically necessary.

Yet public funds cover them. In 2023, Medicaid spent about $31 million on such care for those under 18, mostly non-surgical. This uses taxpayer dollars for what many view as elective changes. Private insurance often follows, raising premiums for all.

The Trump administration proposed rules in late 2025 to prohibit federal Medicaid and CHIP funding for these services in minors and bar hospitals from providing them if they accept Medicare/Medicaid funds. These aim to end public subsidies.

Bills like the No Subsidies for Gender Transition Procedures Act seek to deny tax deductions and federal funding entirely. With evidence quality rated low and harms emerging, forcing taxpayers to subsidize remains unjustified.

The Bottom Line

Whether gender affirming care stems from a mental disorder needing proper psychiatric treatment or is elective and cosmetic, the current push for affirmation and public funding fails scrutiny. Major groups now question the evidence, malpractice verdicts expose risks, and fiscal responsibility demands an end to taxpayer support.

Protect vulnerable youth from irreversible decisions and stop using public money for experimental or elective procedures. Focus on evidence-based mental health care instead.